Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:11 2024-03-28 pm EDT After market 04:39:13 pm
27.75 USD -0.11% Intraday chart for Pfizer, Inc. 27.76 +0.02%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Pfizer, Astellas' Combination Therapy Application For Bladder Cancer Accepted in China MT
Beijing Outlook, Ex-Dividend Dates Roil Asian Stock Markets MT
Chinese Shares Rebound as Xi Pledges to Bolster Business Environment; Two Shenzhen Debutants Post Strong Gains MT
Trial of Insider Trading Case Against Former Medivation Employee Begins in California MT
Pfizer, FedEx CEOs Reportedly Among Those Slated to Possibly Meet With President Xi Jinping MT
News Highlights : Top Company News of the Day - Tuesday at 7 AM ET DJ
China to speed up 'new productive forces', vice president says RE
European Midday Briefing : Investors Hold Back Ahead of Key Inflation Print DJ
News Highlights : Top Company News of the Day - Tuesday at 5 AM ET DJ
AstraZeneca, Pfizer Pledge Support for Expansion of China's Biopharmaceutical Industry MT
News Highlights : Top Company News of the Day - Tuesday at 3 AM ET DJ
BEIJING-PFIZER CEO: BY END OF 2025 PLAN TO SUBMIT 17 NEW DRUG A… RE
BioNTech gets US agency notice over default on COVID vaccine royalties RE
Moderna, Inc. prepares for the post-Covid era Our Logo
German industry sceptical of China's vow to treat foreign firms equally RE
BioNTech gets notice from US agency over default on COVID vaccine royalties RE
North American Morning Briefing : Tech in Focus on -2- DJ
Q32 Bio Inc. completed the acquisition of Homology Medicines, Inc. from 5AM Venture Management, LLC, Arch Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P. managed by Arch Venture Partners, L.P., Pfizer Inc. and TLS Beta Pte. Ltd. in a reverse merger transaction. CI
Health Care Down as Sector Retreat Continues -- Health Care Roundup DJ
Pfizer Gets European Medical Panel's Recommendation for Emblaveo MT
Argus Downgrades Pfizer to Hold From Buy MT
Haleon buys back shares worth GBP315 million from Pfizer AN
BioNTech's Fourth-Quarter Results Miss Views; Guides 2024 Revenue Decline MT
BioNTech Flags Drop in FY24 Revenue MT
BioNTech Profit Slumps on Lower Covid Vaccine Sales DJ
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.78 USD
Average target price
32.7 USD
Spread / Average Target
+17.72%
Consensus
  1. Stock
  2. Equities
  3. Stock Pfizer, Inc. - Nyse
  4. News Pfizer, Inc.
  5. Pfizer, BioNTech Launch Clinical Study of Omicron-Specific COVID-19 Vaccine